Clinical data | |
---|---|
Other names | L-DopAmide; 3-Hydroxytyrosinamide |
Drug class | Monoamine precursor; Dopamine receptor agonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C9H12N2O3 |
Molar mass | 196.206 g·mol−1 |
3D model (JSmol) | |
| |
|
DopAmide, or L-DopAmide, is a synthetic levodopa (L-DOPA) analogue that can serve as a levodopa and dopamine prodrug and is of potential interest in the treatment of Parkinson's disease.[1][2][3] DopAmide has an amide rather than the carboxyl group of L-DOPA,[2][3] which imparts greater water solubility.[1][2][3] The amide is hydrolyzed back to the acid by aminopeptidase enzymes.[1][2][3]